Cancer peptides of NY-ESO-1/CAG-3
US7084239B1 · kind B1 · utility
8Cited by
3References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 21, 1998 |
| Grant date | Aug 1, 2006 |
| Priority date | — |
| Expiry date | Sep 21, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses the identification, isolation and cloning of a gene encoding a novel cancer antigen NY ESO-1CAG-3 and peptides thereof derived from various open reading frames from the NY ESO-1 gene. The novel cancer antigen and peptides are recognized by cytotoxic T lymphocytes in an HLA restricted manner. The products of the gene are promising candidates for immunotherapeutic strategies for the prevention, treatment and diagnosis of patients with cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.